Literature DB >> 6275893

Fluid phase activation of proenzymic C1r purified by affinity chromatography.

C L Villiers, A M Duplaa, G J Arlaud, M G Colomb.   

Abstract

1. Proenzymic C1r was purified from human plasma in a two-step technique involving indirect affinity chromatography on Sepharose Ig anti-C1s. The capacity of C1r to monomerize at pH 5.0 and to redimerize at neutral pH was used for selective elution of C1r. The yield in purified C1r was 39% from plasma; no trace of contaminating serine proteases was detected from [3H]diisopropyl phosphorofluoridate labelling of C1r. 2. C14 was able to undergo a two-way autoactivation: an intramolecular catalytic process catalysed by proenzymic C1r itself and an intermolecular reaction catalysed by activated C1r formed in the process of the reaction. DFP (5mM) and C1 Inh at a C1 Inh/C1r ratio of 1:1 were effective on the solely intermolecular activation, leading to partial inhibition of the autoactivation from proenzymic C1r: C1r formed during the activation was titrated by the inhibitors. Calcium, high ionic strength or acid pH decreased C1r activation. The pH effect was characterized by a slowed-down reaction below pH 6.0 and no net influence at values as high as 10.5. The two types of activation developed similarly as a function of pH. 3. Peripheral iodination of C1r revealed differences in label distribution between proenzymic (A chain moiety 48%, B chain moiety 52%) and activated C1r (A chain 20%, B chain 80%). Two different conformational states of C1r were also suggested by 125I-labelling at different temperatures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6275893     DOI: 10.1016/0167-4838(82)90299-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.

Authors:  M B Lacroix; C A Aude; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

2.  Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.

Authors:  A Reboul; J C Bensa; M G Colomb
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

3.  Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.

Authors:  C Drouet; A Reboul; M Colomb
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Characterization of the C1q receptor on a human macrophage cell line, U937.

Authors:  J Arvieux; A Reboul; J C Bensa; M G Colomb
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

5.  Structural features of the first component of human complement, C1, as revealed by surface iodination.

Authors:  C L Villiers; S Chesne; M B Lacroix; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

6.  Autoactivation of human complement subcomponent C1r involves structural changes reflected in modifications of intrinsic fluorescence, circular dichroism and reactivity with monoclonal antibodies.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

7.  Neutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solution.

Authors:  J Boyd; D R Burton; S J Perkins; C L Villiers; R A Dwek; G J Arlaud
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.

Authors:  N M Thielens; C Illy; I M Bally; G J Arlaud
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

9.  Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.

Authors:  M B Villiers; N M Thielens; M G Colomb
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

10.  Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.

Authors:  J C Bensa; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.